Catawba River Capital Has $7.12 Million Stock Holdings in Transcat, Inc. (NASDAQ:TRNS)

Catawba River Capital increased its holdings in Transcat, Inc. (NASDAQ:TRNS) by 2.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,300 shares of the scientific and technical instruments company’s stock after buying an additional 1,473 shares during the period. Transcat accounts for 4.2% of Catawba River Capital’s holdings, making the stock its 11th largest position. Catawba River Capital owned 0.73% of Transcat worth $7,116,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Conestoga Capital Advisors LLC grew its holdings in Transcat by 17.9% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after acquiring an additional 137,830 shares during the last quarter. Millrace Asset Group Inc. acquired a new stake in Transcat in the third quarter valued at $655,000. State Street Corp raised its position in Transcat by 8.1% during the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after purchasing an additional 15,514 shares during the last quarter. Champlain Investment Partners LLC lifted its holdings in Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after buying an additional 74,169 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after buying an additional 11,106 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Transcat news, Director Craig D. Cairns purchased 1,200 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The stock was bought at an average cost of $77.02 per share, with a total value of $92,424.00. Following the completion of the transaction, the director now owns 1,910 shares of the company’s stock, valued at $147,108.20. The trade was a 169.01 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 2.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on TRNS shares. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. HC Wainwright dropped their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. Northland Securities restated a “market perform” rating and set a $85.00 target price (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Finally, Craig Hallum lifted their target price on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Transcat presently has an average rating of “Hold” and a consensus price target of $111.50.

Transcat Stock Performance

TRNS opened at $77.88 on Tuesday. The company has a market cap of $725.06 million, a price-to-earnings ratio of 42.10 and a beta of 0.67. The company’s fifty day moving average price is $99.76 and its two-hundred day moving average price is $111.19. Transcat, Inc. has a 1-year low of $73.37 and a 1-year high of $147.12. The company has a current ratio of 2.42, a quick ratio of 3.00 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the prior year, the company posted $0.56 earnings per share. On average, analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.